Fig. 1.
Fig. 1. Primary and secondary structure of human PF4. / (A) The crystal structure of the PF4 tetramer is shown with the lysine residues in the C terminus of PF4 (light blue) and other lysine and arginine residues (dark blue) indicated,2021 forming the proposed heparin-binding domain. Pro37 of HIT site 1 is indicated in green. (B) The sequence of mature human and mouse PF4 (HHHH and MMMM, respectively) and human neutrophil-activating peptide-2 (NAP-2) (NNNN) are shown with identical amino acids (in single-letter codes) in the latter 2, with human PF4 shown by the colons. The conserved cysteine residues are in red and numbered at the top, dividing PF4 into 4 domains. Boxed in gray is HIT site 1.26 A major region of sequence difference between human and mouse PF4 found in the second domain.

Primary and secondary structure of human PF4.

(A) The crystal structure of the PF4 tetramer is shown with the lysine residues in the C terminus of PF4 (light blue) and other lysine and arginine residues (dark blue) indicated,20,21 forming the proposed heparin-binding domain. Pro37 of HIT site 1 is indicated in green. (B) The sequence of mature human and mouse PF4 (HHHH and MMMM, respectively) and human neutrophil-activating peptide-2 (NAP-2) (NNNN) are shown with identical amino acids (in single-letter codes) in the latter 2, with human PF4 shown by the colons. The conserved cysteine residues are in red and numbered at the top, dividing PF4 into 4 domains. Boxed in gray is HIT site 1.26 A major region of sequence difference between human and mouse PF4 found in the second domain.

Close Modal

or Create an Account

Close Modal
Close Modal